Overview

Aims and Scope

The Journal of Gene Medicine is a monthly, international, peer-reviewed journal published by Wiley. Throughout twenty-two-year publication, this journal endeavors to report high-quality research advances in gene medicine that covers, but not limited to the following topics:

  • Mechanisms underlying transfer and action of gene medicines.
  • Application of the new technologies for stem cell modification or nucleic acid-based vaccines/therapeutics or DNA/RNA editing.
  • Novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents
  • Viral and nonviral-based delivery systems for nucleic acids such as siRNA, mRNA, microRNA and DNA/RNA editing tools such as CRISPR-Cas9/12/13, prime editing, ADAR.
  • Refined genome editing tools using nucleic acid /protein combinations
  • Gene transfer and its applications in cell therapy
  • Nanomedicine for gene therapy
  • Gene-based prognostic/diagnostic studies
  • Biomarkers for precision medicine
  • Physically or biologically targeted delivery and gene modulation
  • Ex vivoor in vivo pharmacological studies including animal models, and human clinical trials.
  • Identification of new genetic or epigenetic variations as biomarkers to direct precision medicine
  • Preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis.


Please note that the Journal of Gene Medicine is online-only.
Benefits for our authors:
- No charges for colour figures
- Accepted article PDFs will be published within days of acceptance
- Faster issue publication times for full final articles
- Better integration of online supporting information for articles

 

Readership

Basic and Clinical Scientists working in the fields of Gene Transfer and Repair, Oncologists, Neurologists, Geneticists, Virologists.

 

Keywords

gene therapy, gene transfer, genetic medicine, gene expression, cellular reprogramming, viral vectors, retrovirus, retroviral, adenovirus, adenoviral, adeno-associated virus, lentivirus, lentiviral, baculovirus, vaccinia virus, oncolytic viruses, oncolytic virotherapy, immunotherapy, non-viral vectors, transfection, transduction, plasmid, DNA, siRNA, RNAi, shRNA, snRNA, mRNA, oligonucleotide, antisense, microRNA, exon skipping, transgene, lipofection, liposomal, electrotransfer, cell-penetrating peptides, stem cells, induced pluripotent stem cells, embryonic stem cells, cell therapy, cellular therapy,nanomedicine, and vaccine and DNA vaccine.

 

Abstracting and Indexing Information
  • BIOBASE: Current Awareness in Biological Sciences (Elsevier)
  • Biological Abstracts (Clarivate Analytics)
  • Biological Science Database (ProQuest)
  • BIOSIS Previews (Clarivate Analytics)
  • Biotechnology Citation Index (Clarivate Analytics)
  • CAS: Chemical Abstracts Service (ACS)
  • Chemical Abstracts Service/SciFinder (ACS)
  • Current Contents: Life Sciences (Clarivate Analytics)
  • Embase (Elsevier)
  • Health & Medical Collection (ProQuest)
  • Health Research Premium Collection (ProQuest)
  • Hospital Premium Collection (ProQuest)
  • Journal Citation Reports/Science Edition (Clarivate Analytics)
  • Medical Database (ProQuest)
  • MEDLINE/PubMed (NLM)
  • Natural Science Collection (ProQuest)
  • ProQuest Central (ProQuest)
  • ProQuest Central K-324
  • Proquest Pharma Collection (ProQuest)
  • PubMed Dietary Supplement Subset (NLM)
  • Science Citation Index (Clarivate Analytics)
  • Science Citation Index Expanded (Clarivate Analytics)
  • SciTech Premium Collection (ProQuest)
  • SCOPUS (Elsevier)
  • Web of Science (Clarivate Analytics)